Lipella Pharmaceuticals Beheer
Beheer criteriumcontroles 2/4
Lipella Pharmaceuticals' CEO is Jon Kaufman, appointed in Jan 2005, has a tenure of 19.83 years. total yearly compensation is $323.38K, comprised of 63.1% salary and 36.9% bonuses, including company stock and options. directly owns 9.29% of the company’s shares, worth $349.83K. The average tenure of the management team and the board of directors is 17.3 years and 2.7 years respectively.
Belangrijke informatie
Jon Kaufman
Algemeen directeur
US$323.4k
Totale compensatie
Percentage CEO-salaris | 63.1% |
Dienstverband CEO | 19.8yrs |
Eigendom CEO | 9.3% |
Management gemiddelde ambtstermijn | 17.3yrs |
Gemiddelde ambtstermijn bestuur | 2.7yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$4m |
Mar 31 2024 | n/a | n/a | -US$5m |
Dec 31 2023 | US$323k | US$204k | -US$5m |
Sep 30 2023 | n/a | n/a | -US$4m |
Jun 30 2023 | n/a | n/a | -US$4m |
Mar 31 2023 | n/a | n/a | -US$3m |
Dec 31 2022 | US$183k | US$183k | -US$3m |
Sep 30 2022 | n/a | n/a | -US$3m |
Jun 30 2022 | n/a | n/a | -US$2m |
Mar 31 2022 | n/a | n/a | -US$2m |
Dec 31 2021 | US$914k | US$183k | -US$2m |
Dec 31 2020 | US$183k | US$183k | -US$62k |
Compensatie versus markt: Jon's total compensation ($USD323.38K) is below average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Jon's compensation has increased whilst the company is unprofitable.
CEO
Jon Kaufman (58 yo)
19.8yrs
Tenure
US$323,383
Compensatie
Dr. Jonathan Kaufman, also known as Jon, PhD, MBA, co-founded Lipella Pharmaceuticals Inc. in 2005 and serves as its President, Chief Executive Officer, Secretary and Treasurer and Chairman of the Board of...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 19.8yrs | US$323.38k | 9.29% $ 349.8k | |
Co-Founder | 19.8yrs | US$315.08k | 9.07% $ 341.6k | |
Chief Financial Officer | 2yrs | US$260.00k | 0% $ 0 | |
Director of Operations | 14.7yrs | geen gegevens | 0% $ 0 | |
Controller | no data | geen gegevens | geen gegevens |
17.3yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren management: LIPO's management team is seasoned and experienced (17.3 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 19.8yrs | US$323.38k | 9.29% $ 349.8k | |
Co-Founder | 16.8yrs | US$315.08k | 9.07% $ 341.6k | |
Member of Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Advisory Board | no data | geen gegevens | 5.74% $ 216.2k | |
Independent Director | 3.2yrs | US$62.50k | 0% $ 0 | |
Member of Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens | |
Independent Director | 2.7yrs | US$63.30k | 0% $ 0 | |
Independent Director & Member of Advisory Board | 3.2yrs | US$62.50k | 0% $ 0 | |
Chair of the Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 1.7yrs | geen gegevens | geen gegevens |
2.7yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren bestuur: LIPO's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.